The Association of British Clinical Diabetologists nationwide exenatide and liraglutide audits suggest a low incidence of acute pancreatitis. Response to Robson. Incretins and pancreatitis--what happens next? A personal viewpoint

Diabet Med. 2013 Dec;30(12):1510-1. doi: 10.1111/dme.12336.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Cardiovascular Diseases / drug therapy*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetic Angiopathies / drug therapy*
  • Female
  • Humans
  • Incretins / adverse effects*
  • Male
  • Pancreatitis / chemically induced*

Substances

  • Incretins